Related Experiment Video
Updated: May 27, 2025

10:37
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
78
Associations Between Gut Microbiota and Diabetic Nephropathy: A Mendelian Randomization Study
Yujun Xiong1, Xingyun Zhu2, Huazhao Xu3
1Department of Gastroenterology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine Chinese Academy of Medical Sciences Beijing China.
Aging Medicine (Milton (N.S.W))
|February 19, 2025
Summary
This study investigated the causal link between gut microbiota and diabetic nephropathy (DN) using Mendelian randomization. Specific gut microbes were identified as potentially causing or protecting against DN, offering new therapeutic targets.
Area of Science:
- Microbiome research
- Genetics
- Nephrology
Background:
- Diabetic nephropathy (DN) is a serious diabetes complication with unclear causes.
- The gut microbiome's role in DN pathogenesis is an emerging area of research.
Purpose of the Study:
- To explore the potential causal relationship between gut microbiota and diabetic nephropathy.
- To identify specific gut microbial species associated with DN using a two-sample Mendelian randomization (MR) approach.
Main Methods:
- Utilized large-scale genome-wide association studies (GWAS) data for gut microbiota (MiBioGen) and DN (FinnGen).
- Employed the inverse variance-weighted (IVW) method for primary MR analysis.
- Conducted sensitivity analyses to ensure the robustness of findings against pleiotropy and heterogeneity.
Main Results:
- Identified fourteen gut microbial species with significant genetic associations with DN.
- Nine species showed a positive causal association, while five exhibited a negative association with DN.
- Confirmed the absence of significant pleiotropy or heterogeneity, supporting the reliability of the results.
Conclusions:
- This research provides novel evidence for a causal role of gut microbiota in diabetic nephropathy.
- Specific gut microbial species are implicated in DN pathogenesis, suggesting potential therapeutic targets.
- Findings open new avenues for research and the development of microbiome-based interventions for DN.

